New Venture Utilizing PeopleMed(R), Inc. Subsidiary in Highly Lucrative Previously Third-Party Market DENVER, Nov. 6 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) , an international e-Health, medical information technology company, announced today that its PeopleMed, Inc. (PeopleMed) subsidiary will now be offering complete validation and consulting services, primarily in the donor center and hospital laboratory markets, to assist facilities with the transition during software system implementation. The need for validation and software consulting services is growing due to the rapid adoption of new information technology within the healthcare space. Prior to entering this business, the Company referred customers to various third-party providers for these services. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) Global Med Technologies' Wyndgate Technologies(R) (Wyndgate) division manufactures medical device software for use in blood donor centers and hospital transfusion services. The United States Food and Drug Administration (FDA) and other regulatory agencies require that, as medical devices, Wyndgate's products must be validated before being used to manage the blood supply. Increasingly, blood center and transfusion staffs are short-handed and struggle to meet daily workload. It is difficult to add validation requirements to this burden for short-staffed facilities. This trend has grown over the past few years, creating added demand for Global Med Technologies' services. This demand prompted the Company to realign its PeopleMed subsidiary's business operation to meet the increasing needs of customers for validation services. Additionally, blood donor center and hospital transfusion service clients of the Company's Wyndgate division are increasingly in need of expert assistance with Standard Operating Procedures (SOPs), independent software validation, upload of data converted from legacy systems and other consulting services. PeopleMed fulfills this demand by helping clients to better and more efficiently utilize Wyndgate's SafeTrace(R), SafeTrace Tx(R), and El Dorado Donor Doc(TM) products. Tom Marcinek, President and COO of Global Med Technologies, Inc., stated, "The establishment of this new service within the PeopleMed subsidiary allows customers to obtain assistance from the experts who know the Company's products best while maintaining independent objectivity as a separate business unit distinct from Wyndgate Technologies' operations. Customers have been asking us for these services for some time." Mr. Marcinek further stated, "Offering these services through our PeopleMed subsidiary allows us to maintain objective independence from the Wyndgate division operation and provide confidence that all services are provided by the most qualified, knowledgeable experts who are a part of the Global Med Technologies' family of companies. Our goal is to provide a level of service and efficiency that exceeds current offerings in the marketplace." PeopleMed's service offerings are not limited to Wyndgate's products, nor are they restricted to the template, off-the-shelf services common among third-party providers today. PeopleMed offers a full menu of choices combined with consulting services to help ease the transition of system implementation. This independent objectivity, combined with the expert knowledge of Global Med Technologies' resources and the unparalleled coordination with the Wyndgate implementation team, will better allow customers to move forward with confidence as they implement new software solutions. About Global Med Technologies, Inc. Global Med Technologies(R), Inc. is an international e-Health medical information technology company providing information management software products and services to the healthcare industry. Its Wyndgate Technologies(R) division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Each year, Wyndgate's products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply. Wyndgate's products are also being used in Canada and sub-Saharan Africa, and are being implemented in the Caribbean. Together, the Donor Doc(TM) interactive donor health history questionnaire, SafeTrace(R) donor management system, and the SafeTrace Tx(R) advanced transfusion management system, recently patented, provide Vein-to-Vein(R) tracking from donor collection to patient transfusion. For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com/ , http://www.peoplemed.com/ and http://www.wyndgate.com/. This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGODATASOURCE: Global Med Technologies, Inc. CONTACT: Company, Michael I. Ruxin, M.D. of Global Med Technologies, Inc., +1-303-238-2000, ; or Investors, Paul Holm of H.L. Lanzet, Inc., +1-212-888-4570, Web site: http://www.globalmedtech.com/

Copyright